PassFinals
Obstetrics

Venous Thromboembolism in Pregnancy

Pregnancy and the puerperium increase venous thromboembolism risk through hypercoagulability, venous stasis and vascular injury; suspected deep-vein thrombosis or pulmonary embolism needs prompt objective testing and therapeutic low-molecular-weight heparin unless strongly contraindicated.

In a nutshell

Pregnancy and the puerperium increase VTE risk. Suspected DVT or PE needs urgent objective testing and therapeutic LMWH unless strongly contraindicated. Use compression duplex ultrasound for DVT; for suspected PE obtain ECG and chest X-ray, then V/Q or CTPA, with CTPA preferred when the chest X-ray is abnormal. D-dimer is not used to exclude pregnancy-associated VTE. Treat confirmed VTE with LMWH for the remainder of pregnancy, at least 6 weeks postpartum and at least 3 months total; plan the last dose around labour and neuraxial anaesthesia.

Classic presentation

A postpartum patient has a painful swollen left leg, or develops sudden breathlessness, pleuritic chest pain, tachycardia or hypoxia. Start LMWH while arranging objective testing and escalate immediately if unstable.

Key points

  • The puerperium is the highest-risk period and risk assessment must be repeated.
  • Do not use D-dimer to rule out VTE in pregnancy.
  • Start therapeutic LMWH on suspicion unless strongly contraindicated; do not wait for imaging.
  • For suspected PE, ECG and chest X-ray precede V/Q or CTPA; confirmed DVT with PE symptoms needs no further PE imaging for treatment purposes.
  • Treat confirmed VTE for the remainder of pregnancy, at least 6 weeks postpartum and at least 3 months total.
  • Allow at least 24 hours after a therapeutic LMWH dose before regional anaesthesia; make an antenatal delivery plan.

First-line investigation

Compression duplex ultrasound for suspected DVT; ECG and chest X-ray followed by V/Q or CTPA for suspected PE.

Management

Stabilise and anticoagulate on suspicion

  • Assess ABCDE and bleeding risk, start therapeutic LMWH unless strongly contraindicated, obtain baseline bloods and arrange urgent objective testing; escalate unstable PE to critical care and the multidisciplinary team.3,5

Confirm with the pregnancy pathway

  • Use compression duplex for suspected DVT; for PE obtain ECG and chest X-ray, then V/Q or CTPA, with CTPA preferred if the chest X-ray is abnormal.3

Treat and plan around birth

  • Continue LMWH through pregnancy and postpartum for the required duration, involve haematology and anaesthesia, and plan interruption for labour, induction, caesarean birth and neuraxial analgesia.3,5

Prevent recurrence and harm

  • Use the RCOG risk tool for prophylaxis, reassess after birth, teach injection and bleeding safety-netting, and choose postpartum anticoagulation and breastfeeding-compatible treatment with specialist advice.1,2,4

Exam traps

  • A normal D-dimer does not replace the RCOG imaging pathway and an elevated D-dimer is expected in pregnancy.
  • Do not delay LMWH while awaiting CTPA or V/Q if clinical suspicion is significant.
  • A negative DVT ultrasound with high clinical suspicion needs repeat specialist assessment rather than automatic reassurance.
  • Stop prophylactic LMWH when labour begins; planned therapeutic LMWH is usually withheld 24 hours before birth.
  • The minimum treatment duration is both at least 3 months total and at least 6 weeks postpartum.
  • Do not offer neuraxial anaesthesia within 24 hours of the last therapeutic LMWH dose.

Illustrations

Deep vein thrombosis on compression ultrasoundCompression ultrasound showing a non-compressible left common femoral vein containing thrombus, illustrating the key finding in suspected pregnancy-associated DVT.Serrano Reyes JC et al., Cureus 2025, CC-BY-4.0 · CC-BY-4.0

Key sources

  1. RCOG Green-top Guideline No. 37a, Reducing the Risk of Thrombosis and Embolism during Pregnancy and the Puerperium (Third edition published April 2015 and amended 2023: RCOG prevention and risk-assessment tool, antenatal and postnatal prophylaxis and labour or regional-anaesthesia planning; fourth edition is in development)
  2. NICE NG89, Venous thromboembolism in over 16s: reducing the risk of hospital-acquired DVT or PE (NICE recommendations last updated 13 August 2019 and last reviewed 18 September 2024: hospital risk assessment, pregnancy admission prophylaxis, active labour and post-event timing)Updated 13 Aug 2019
  3. RCOG Green-top Guideline No. 37b, Thromboembolic Disease in Pregnancy and the Puerperium: Acute Management (Third edition published April 2015: objective investigation, empiric LMWH, ultrasound, CTPA or V/Q imaging, treatment duration, delivery planning and life-threatening PE management)
  4. RCOG patient information, Diagnosis and treatment of venous thrombosis in pregnancy and after birth (RCOG information based on GTG37b: symptoms, investigation, LMWH treatment duration, labour, neuraxial timing and breastfeeding)
  5. BNF, current low-molecular-weight heparin and anticoagulant prescribing information (UK prescribing source for LMWH product selection, treatment and prophylaxis dosing, renal impairment, adverse effects and postpartum anticoagulant choice; direct access was restricted and unsupported dosing was deferred to BNF and local protocols)
  6. RCOG Green-top Guideline No. 56, Maternal Collapse in Pregnancy and the Puerperium (Current RCOG maternal-collapse guidance reviewed in December 2024 and extended for 2 years: resuscitation and multidisciplinary management of life-threatening maternal collapse)Updated 1 Dec 2024

This page is exam revision material, not medical advice, and must not be used for patient care. Always check drug doses against the BNF and current guidance. Full disclaimer.